C07D 491/14
Ortho-condensed systems
C07D491/14 (Ortho-condensed systems) appears on 818 US grants and 927 published applications in this corpus.
Search patents in C07D- Granted patents
- 818
- Published applications
- 927
- Assignees
- 532
- Inventors
- 3,232
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 4 | 0 |
| 1978 | 7 | 0 |
| 1979 | 3 | 0 |
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 2 | 0 |
| 1983 | 7 | 0 |
| 1984 | 8 | 0 |
| 1985 | 6 | 0 |
| 1986 | 6 | 0 |
| 1987 | 8 | 0 |
| 1988 | 5 | 0 |
| 1989 | 6 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 12 | 0 |
| 1993 | 12 | 0 |
| 1994 | 6 | 0 |
| 1995 | 11 | 0 |
| 1996 | 23 | 0 |
| 1997 | 14 | 0 |
| 1998 | 10 | 0 |
| 1999 | 9 | 0 |
| 2000 | 12 | 0 |
| 2001 | 17 | 2 |
| 2002 | 12 | 14 |
| 2003 | 14 | 19 |
| 2004 | 8 | 29 |
| 2005 | 16 | 29 |
| 2006 | 18 | 33 |
| 2007 | 18 | 32 |
| 2008 | 18 | 25 |
| 2009 | 18 | 36 |
| 2010 | 22 | 27 |
| 2011 | 17 | 34 |
| 2012 | 15 | 30 |
| 2013 | 27 | 21 |
| 2014 | 20 | 48 |
| 2015 | 31 | 37 |
| 2016 | 42 | 55 |
| 2017 | 44 | 40 |
| 2018 | 39 | 43 |
| 2019 | 35 | 37 |
| 2020 | 33 | 52 |
| 2021 | 26 | 36 |
| 2022 | 36 | 49 |
| 2023 | 20 | 57 |
| 2024 | 30 | 51 |
| 2025 | 31 | 47 |
| 2026 | 18 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Substituted [1,2,4]triazolo[4,3-a]quinoxalines, dosage forms containing them, and methods of using them to treat or prevent pain and/or inflammation29 Sep 2026US 12,747,240 B2Gruenenthal GmbH
- EIF4A-inhibiting compounds and methods related thereto29 Sep 2026US 12,747,249 B2SJP Biotec GmbH
- 5-amino-6,8-dihydro-1H-furo[3,4-d]pyrrolo[3,2-b]pyridine-2-carboxamide derivatives as MTA-cooperative inhibitors of PRMT51 Sep 2026US 12,723,048 B2BeOne Medicines | GmbH
- Long stokes shift chromenoquinoline dyes and uses in sequencing applications1 Sep 2026US 12,723,279 B2Illumina Cambridge Limited
- Compound, cellular vesicle staining agent, and method of fluorescent staining for cellular vesicles11 Aug 2026US 12,704,443 B2National University Corporation Tokai National Higher Education and Research System
- Inhibitors of parg24 Sep 2026US 2026/0285875 A1858 Therapeutics, Inc.
- 3h-pyrazolo[4.3:f] quinoline-based compounds as sting antagonists17 Sep 2026US 2026/0274838 A1Purdue Research Foundation
- Immunomodulator3 Sep 2026US 2026/0258050 A1Hitgen Inc.
- Compounds as prmt5 degraders and uses thereof27 Aug 2026US 2026/0250268 A1
- Process for synthesizing naphthyridine derivatives and intermediates thereof27 Aug 2026US 2026/0250296 A1Amgen Inc.
Most cited
By later US patents
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997
- Sulfonated xanthene derivatives204US 6,130,101 AMolecular Probes, Inc. · 2000
- Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes164US 5,227,487 AMolecular Probes, Inc. · 1993
- Dimeric and trimeric nucleic acid dyes, and associated systems and methods164US 7,776,567 B2AlleLogic Biosciences Corporation · 2010
- Biological conjugates of fluorescent rhodol dyes133US 5,442,045 AMolecular Probes, Inc. · 1995